Jason Hsu - Net Worth and Insider Trading

Jason Hsu Net Worth

The estimated net worth of Jason Hsu is at least $11 Million dollars as of 2024-05-24. Jason Hsu is the Director of Immix Biopharma Inc and owns about 4,778,913 shares of Immix Biopharma Inc (IMMX) stock worth over $11 Million. Details can be seen in Jason Hsu's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jason Hsu has not made any transactions after 2023-12-11 and currently still holds the listed stock(s).

Transaction Summary of Jason Hsu

To

Jason Hsu Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jason Hsu owns 1 companies in total, including Immix Biopharma Inc (IMMX) .

Click here to see the complete history of Jason Hsu’s form 4 insider trades.

Insider Ownership Summary of Jason Hsu

Ticker Comapny Transaction Date Type of Owner
IMMX Immix Biopharma Inc 2023-12-11 director

Jason Hsu Latest Holdings Summary

Jason Hsu currently owns a total of 1 stock. Jason Hsu owns 4,778,913 shares of Immix Biopharma Inc (IMMX) as of December 11, 2023, with a value of $11 Million.

Latest Holdings of Jason Hsu

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IMMX Immix Biopharma Inc 2023-12-11 4,778,913 2.25 10,752,554

Holding Weightings of Jason Hsu


Jason Hsu Form 4 Trading Tracker

According to the SEC Form 4 filings, Jason Hsu has made a total of 4 transactions in Immix Biopharma Inc (IMMX) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Immix Biopharma Inc is the acquisition of 56,000 shares on December 11, 2023, which cost Jason Hsu around $267,120.

Insider Trading History of Jason Hsu

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jason Hsu Trading Performance

GuruFocus tracks the stock performance after each of Jason Hsu's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jason Hsu is 49.25%. GuruFocus also compares Jason Hsu's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jason Hsu within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jason Hsu's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jason Hsu

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 39.87
Relative Return to S&P 500(%) 41.01

Jason Hsu Ownership Network

Ownership Network List of Jason Hsu

No Data

Ownership Network Relation of Jason Hsu


Jason Hsu Owned Company Details

What does Immix Biopharma Inc do?

Who are the key executives at Immix Biopharma Inc?

Jason Hsu is the director of Immix Biopharma Inc. Other key executives at Immix Biopharma Inc include director & CEO and Chairman Ilya M Rachman , director & Chief Financial Officer Gabriel S Morris , and director & 10 percent owner Yekaterina Chudnovsky .

Immix Biopharma Inc (IMMX) Insider Trades Summary

Over the past 18 months, Jason Hsu made 3 insider transaction in Immix Biopharma Inc (IMMX) with a net purchase of 138,000. Other recent insider transactions involving Immix Biopharma Inc (IMMX) include a net purchase of 20,000 shares made by Magda Marquet , a net purchase of 20,000 shares made by Melissa Jane Buchan , and a net purchase of 13,000 shares made by Helen C. Adams .

In summary, during the past 3 months, insiders sold 0 shares of Immix Biopharma Inc (IMMX) in total and bought 8,800 shares, with a net purchase of 8,800 shares. During the past 18 months, 0 shares of Immix Biopharma Inc (IMMX) were sold and 209,800 shares were bought by its insiders, resulting in a net purchase of 209,800 shares.

Immix Biopharma Inc (IMMX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Immix Biopharma Inc Insider Transactions

No Available Data

Jason Hsu Mailing Address

Above is the net worth, insider trading, and ownership report for Jason Hsu. You might contact Jason Hsu via mailing address: 11400 West Olympic Blvd., Suite 200, Los Angeles Ca 90064.

Discussions on Jason Hsu

No discussions yet.